[Skip to Navigation]
Sign In

October 2024 - July 1883

Decade

Year

Issue

September 19, 2023, Vol 330, No. 11, Pages 1023-1107

This Week in JAMA

Audio Highlights

Abstract Full Text
free access online only has audio
JAMA. 2023;330(11):e2216052. doi:10.1001/jama.2022.16052
Original Investigation

Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial

Abstract Full Text
free access has active quiz has audio
JAMA. 2023;330(11):1054-1063. doi:10.1001/jama.2023.15694

This follow-up study of a randomized clinical trial examines the effect of minimally invasive surfactant therapy, surfactant administration via a thin catheter, on death or neurodevelopmental disability at 2 years’ corrected age.

Treatment Failure and Adverse Events After Amoxicillin-Clavulanate vs Amoxicillin for Pediatric Acute Sinusitis

Abstract Full Text
free access
JAMA. 2023;330(11):1064-1073. doi:10.1001/jama.2023.15503

This cohort study compares the rate of treatment failure and adverse events associated with amoxicillin-clavulanate vs amoxicillin in children newly diagnosed with acute sinusitis in an outpatient setting.

Preliminary Communication

Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA. 2023;330(11):1042-1053. doi:10.1001/jama.2023.16503

This phase 1 randomized clinical trial evaluates the safety, tolerability, pharmacokinetics, and exploratory pharmacodynamic biomarker effects of muvalaplin in humans.

Research Letter

Financial Conflicts of Interest in Public Comments on Medicare National Coverage Determinations of Medical Devices

Abstract Full Text
free access
JAMA. 2023;330(11):1094-1096. doi:10.1001/jama.2023.14414

This study reviewed public comments for all Medicare National Coverage Determinations between June 2019 and 2022 on select pulmonary and cardiac devices to determine whether financial conflicts of interest were disclosed.

US Preventive Services Task Force

Recommendation Statement

Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement

Abstract Full Text
free access has active quiz has audio
JAMA. 2023;330(11):1074-1082. doi:10.1001/jama.2023.16991

This 2023 Recommendation Statement from the US Preventive Services Task Force recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy (B recommendation).

Evidence Report

Screening for Hypertensive Disorders of Pregnancy: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Abstract Full Text
free access has active quiz has audio
JAMA. 2023;330(11):1083-1091. doi:10.1001/jama.2023.4934

This systematic review to support the 2023 US Preventive Services Task Force Recommendation Statement on screening for hypertensive disorders of pregnancy summarizes published evidence on the benefits and harms of screening for hypertensive disorders of pregnancy using in-person and home-based blood pressure measurement.

Viewpoint

Affirmative Action Ruled Unconstitutional: Options for Building a Diverse Health Care Workforce

Abstract Full Text
JAMA. 2023;330(11):1031-1032. doi:10.1001/jama.2023.14886

This Viewpoint reviews how the recent US Supreme Court decision regarding affirmative action affects extant medical school admission policies seeking to enhance diversity of the national medical student body and its derivative national health care workforce.

The Supreme Court’s Rulings on Race Neutrality Threaten Progress in Medicine and Health

Abstract Full Text
JAMA. 2023;330(11):1033-1034. doi:10.1001/jama.2023.13749

This Viewpoint examines the recent Supreme Court rulings on race neutrality, striking down affirmative action programs in higher education, which will affect efforts to eliminate health inequities in the US.

The Supreme Court Decision on Affirmative Action—Fewer Black Physicians and More Health Disparities for Minoritized Groups

Abstract Full Text
JAMA. 2023;330(11):1035-1036. doi:10.1001/jama.2023.15515

This Viewpoint discusses the US Supreme Court’s June 2023 ruling on affirmative action and its repercussions for Black physicians and health equity for racial and ethnic minority groups.

Holistic Admissions at UC Davis—Journey Toward Equity

Abstract Full Text
JAMA. 2023;330(11):1037-1038. doi:10.1001/jama.2023.15872

This Viewpoint discusses what higher education institutions can learn from UC Davis when it comes to ensuring equity for their students now that the US Supreme Court has eliminated race-conscious college admissions.

A Piece of My Mind

“On Home”

Abstract Full Text
JAMA. 2023;330(11):1039. doi:10.1001/jama.2023.15886

In this narrative medicine essay, a physician in training describes what it means to come home during her journey in pursuit of a medical career.

Editorial

Hypertension Screening in Pregnancy: Remembering the Basics, Charting the Future

Abstract Full Text
has audio
JAMA. 2023;330(11):1040-1041. doi:10.1001/jama.2023.15088
JAMA Clinical Challenge

Rash and Poor Wound Healing After Mastectomy

Abstract Full Text
has active quiz
JAMA. 2023;330(11):1092-1093. doi:10.1001/jama.2023.16367

A patient who had recently undergone bilateral mastectomy had erythema, edema, pain, pruritus, serous fluid drainage at the incision sites, and an erythematous papulovesicular rash on the trunk and extremities. A skin swab bacterial culture result was negative, and the skin findings did not improve with antibiotics. What is the diagnosis and what would you do next?

Medical News & Perspectives

How the New 988 Lifeline Is Helping Millions in Mental Health Crisis

Abstract Full Text
JAMA. 2023;330(11):1025-1028. doi:10.1001/jama.2023.14440

This Medical News article discusses the successes and challenges of the 988 Suicide & Crisis Lifeline following its first anniversary.

Medical News in Brief

CDC Assesses Risk From BA.2.86, Highly Mutated COVID-19 Variant

Abstract Full Text
has audio
JAMA. 2023;330(11):1029. doi:10.1001/jama.2023.16105

FDA Approves Maternal RSV Vaccine

Abstract Full Text
JAMA. 2023;330(11):1029. doi:10.1001/jama.2023.16106

Most Fish Oil Supplements Make Unsupported Claims

Abstract Full Text
JAMA. 2023;330(11):1029. doi:10.1001/jama.2023.16107

One in 5 Males Worldwide Has High-Risk Genital HPV

Abstract Full Text
JAMA. 2023;330(11):1029. doi:10.1001/jama.2023.16108

Severe COVID-19 Linked to Enduring Immune System Changes

Abstract Full Text
JAMA. 2023;330(11):1030. doi:10.1001/jama.2023.16109

Artemisinin Resistance Increasing

Abstract Full Text
JAMA. 2023;330(11):1030. doi:10.1001/jama.2023.16110

Binge Drinking, Other Substance Use Up in Midlife Adults

Abstract Full Text
JAMA. 2023;330(11):1030. doi:10.1001/jama.2023.16111

Deep Brain Stimulation May Improve Function Years After Stroke

Abstract Full Text
JAMA. 2023;330(11):1030. doi:10.1001/jama.2023.16112
Poetry and Medicine

Virus

Abstract Full Text
JAMA. 2023;330(11):1102. doi:10.1001/jama.2023.18509
JAMA Revisited

Of Dictionaries, Old and New

Abstract Full Text
JAMA. 2023;330(11):1103. doi:10.1001/jama.2022.16053
JAMA Patient Page

Screening for High Blood Pressure Disorders During Pregnancy

Abstract Full Text
free access has audio
JAMA. 2023;330(11):1107. doi:10.1001/jama.2023.17046

This JAMA Patient Page describes the pros and cons of screening for high blood pressure disorders during pregnancy, and who should be screened.

Comment & Response

Housing Mobility Intervention for Childhood Asthma

Abstract Full Text
JAMA. 2023;330(11):1096. doi:10.1001/jama.2023.12733

Housing Mobility Intervention for Childhood Asthma—Reply

Abstract Full Text
JAMA. 2023;330(11):1097. doi:10.1001/jama.2023.12736

Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy

Abstract Full Text
JAMA. 2023;330(11):1097-1098. doi:10.1001/jama.2023.12776

Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy

Abstract Full Text
JAMA. 2023;330(11):1098. doi:10.1001/jama.2023.12773

Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy

Abstract Full Text
JAMA. 2023;330(11):1098-1099. doi:10.1001/jama.2023.12770

Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy—Reply

Abstract Full Text
JAMA. 2023;330(11):1099-1100. doi:10.1001/jama.2023.12779

Censorship of the Patient-Physician Relationship

Abstract Full Text
JAMA. 2023;330(11):1100. doi:10.1001/jama.2023.13168

Censorship of the Patient-Physician Relationship—Reply

Abstract Full Text
JAMA. 2023;330(11):1100-1101. doi:10.1001/jama.2023.13171
Correction

Figure Label Correction

Abstract Full Text
free access
JAMA. 2023;330(11):1101. doi:10.1001/jama.2023.17516

Addition of Group Name in Byline and Nonauthor Collaborators Supplement

Abstract Full Text
free access
JAMA. 2023;330(11):1101. doi:10.1001/jama.2023.17655
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2023;330(11):1023-1024. doi:10.1001/jama.2022.16051
×